Crossmark

In vivo pharmacokinetic/Pharmacodynamic modeling of Enrofloxacin against Escherichia coli in broiler chickens

Crossref DOI link: https://doi.org/10.1186/s12917-018-1698-3

Published Online: 2018-11-29

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xiao, Xia

Jiang, Lijie

Lan, Weixuan

Jiang, Yongjia

Wang, Zhiqiang https://orcid.org/0000-0001-6486-9600
Funding

Funding for this research was provided by:

the National Key Research and Development Program of China (2016YFD0501310)

National Natural Science Foundation of China (31702291, 31872526)

the Priority Academic Program Development of Jiangsu Higher Education Institutions
License Information

Text and Data Mining valid from 2018-11-29
More Information

Article History

Received: 6 February 2018

Accepted: 19 November 2018

First Online: 29 November 2018

Ethics approval and consent to participate

: The animals were maintained according to the National Standards for Laboratory Animals of China (GB 14925–2010). This study was approved by the Animal Experiments Ethics Committee at Yangzhou University (SYXK(Su) IACUC 2017–0045).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.